Search Results - "Terleira‐Fernández, Ana‐Isabel"

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Causes of Death in Anticoagulated Patients With Atrial Fibrillation by Gómez-Outes, Antonio, MD, PhD, Lagunar-Ruíz, Julián, MD, Terleira-Fernández, Ana-Isabel, MD, PhD, Calvo-Rojas, Gonzalo, MD, PhD, Suárez-Gea, Maria Luisa, PharmD, PhD, Vargas-Castrillón, Emilio, MD, PhD

    “…Abstract Background Oral anticoagulation reduces the risk of mortality in atrial fibrillation (AF), but examination of the causes of death is essential to…”
    Get full text
    Journal Article
  2. 2

    Direct-acting oral anticoagulants: pharmacology, indications, management, and future perspectives by Gómez-Outes, Antonio, Suárez-Gea, Mª Luisa, Lecumberri, Ramón, Terleira-Fernández, Ana Isabel, Vargas-Castrillón, Emilio

    Published in European journal of haematology (01-11-2015)
    “…In recent years, several direct‐acting oral anticoagulants (DOAC) have become available for use in Europe and other regions in indications related to…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review by Gómez-Outes, Antonio, Suárez-Gea, M Luisa, Lecumberri, Ramón, Terleira-Fernández, Ana Isabel, Vargas-Castrillón, Emilio

    Published in Vascular health and risk management (01-01-2014)
    “…Pulmonary embolism (PE) is a relatively common cardiovascular emergency. PE and deep vein thrombosis (DVT) are considered expressions of the same disease,…”
    Get full text
    Journal Article
  5. 5

    Direct oral anticoagulants in the treatment of acute venous thromboembolism: A systematic review and meta-analysis by Gómez-Outes, Antonio, Terleira-Fernández, Ana Isabel, Lecumberri, Ramón, Suárez-Gea, M. Luisa, Vargas-Castrillón, Emilio

    Published in Thrombosis research (01-10-2014)
    “…Abstract Introduction Acute venous thromboembolism (VTE) is a common disease associated to significant morbidity and mortality. Materials and methods We…”
    Get full text
    Journal Article
  6. 6

    Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain by Gómez-Outes, Antonio, Avendaño-Solá, Cristina, Terleira-Fernández, Ana Isabel, Vargas-Castrillón, Emilio

    Published in PharmacoEconomics (01-09-2014)
    “…Background Patients undergoing total hip replacement (THR) or total knee replacement (TKR) surgery are at high risk of developing venous thromboembolism (VTE)…”
    Get full text
    Journal Article
  7. 7

    Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants by Gómez-Outes, Antonio, Alcubilla, Pau, Calvo-Rojas, Gonzalo, Terleira-Fernández, Ana Isabel, Suárez-Gea, Ma Luisa, Lecumberri, Ramón, Vargas-Castrillón, Emilio

    “…Direct oral anticoagulants (DOACs) have shown a positive benefit-risk balance in both clinical trials and real-world data, but approximately 2% to 3.5% of…”
    Get full text
    Journal Article
  8. 8

    Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons by Gómez-Outes, Antonio, Terleira-Fernández, Ana Isabel, Suárez-Gea, M Luisa, Vargas-Castrillón, Emilio

    Published in BMJ (Online) (14-06-2012)
    “…Objective To analyse clinical outcomes with new oral anticoagulants for prophylaxis against venous thromboembolism after total hip or knee replacement.Design…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Discovery of anticoagulant drugs: a historical perspective by Gómez-Outes, Antonio, Suárez-Gea, Ma Luisa, Calvo-Rojas, Gonzalo, Lecumberri, Ramón, Rocha, Eduardo, Pozo-Hernández, Carmen, Terleira-Fernández, Ana Isabel, Vargas-Castrillón, Emilio

    Published in Current drug discovery technologies (01-06-2012)
    “…The history of the traditional anticoagulants is marked by both perseverance and serendipity. The anticoagulant effect of heparin was discovered by McLean in…”
    Get more information
    Journal Article
  11. 11

    Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients by Gómez-Outes, Antonio, Suárez-Gea, M Luisa, Lecumberri, Ramón, Terleira-Fernández, Ana Isabel, Vargas-Castrillón, Emilio, Rocha, Eduardo

    Published in Vascular health and risk management (01-01-2013)
    “…Venous thromboembolism (VTE), encompassing deep vein thrombosis and pulmonary embolism, represents a major cause of morbidity and mortality in patients with…”
    Get full text
    Journal Article
  12. 12

    Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation : A Systematic Review and Meta-Analysis of Subgroups by Gómez-Outes, Antonio, Terleira-Fernández, Ana Isabel, Calvo-Rojas, Gonzalo, Suárez-Gea, M. Luisa, Vargas-Castrillón, Emilio

    Published in Thrombosis (01-01-2013)
    “…Background. New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have become available as an alternative to warfarin anticoagulation in…”
    Get full text
    Journal Article
  13. 13